The effect of telmisartan in hypertensive patients with obstructive sleep apnea

The effect of telmisartan in hypertensive patients with obstructive sleep apnea - The effect of telmisartan in hypertensive patients with obstructive sleep apnea

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016166

Enrollment

Registered

2015-01-09

Start date

2015-01-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

20mg, 40mg or 80mg of telmisartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with obstructive sleep apnea 2)The untreated hypertensive patients with BP beyond 140/90mmHg, or the uncontrolled hypertensive patients treated with single antihypertensive drugs other than RAS blockades (renin inhibitor, ACE inhibitor, ARB, aldosterone blocker). 3)Patients unavailable on continuous positive airway pressure for any reason.

Exclusion criteria

Exclusion criteria: 1)The subjects who have past medical history of hypersensitivity to telmisartan 2)The subjects during pregnancy or lactation 3)The subjects found offensive by attending physicians for this research

Design outcomes

Primary

Measure	Time frame
autonomic function	—

Secondary

Measure	Time frame
1)polysomnography 2)blood pressure, pulse rate 3)index of oxidative stress	—

Countries

Japan

Contacts

Public ContactNorihisa Ito

Osaka university graduate school of medicine The departent of geriatric medicine and nephrology

itoh@geriat.med.osaka-u.ac.jp06-6879-3852

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026